查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514897

鼻疫苗市場，按疫苗類型、交付方式、分銷、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Nasal Vaccines Market, By Vaccine Type, By Delivery Method, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 357 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年鼻疫苗市場規模為4.189億美元，2024年至2032年複合年成長率為8.56%。

鼻疫苗市場-市場動態

呼吸道感染盛行率上升推動市場成長

呼吸道感染的日益普及正在推動鼻疫苗市場的成長，因為這項技術提供了一種無針的免疫替代方案。據世界衛生組織稱，呼吸道感染佔全球死亡率的很大一部分，光是流感每年就造成約 29 萬至 65 萬人死亡。這種負擔，加上人們對無針疫苗接種的日益偏好，正在推動鼻疫苗市場的發展。例如，最近發表在知名醫學雜誌上的一項研究表明，RSV（呼吸道合胞病毒）鼻疫苗可有效保護嬰兒，凸顯了其潛力。隨著與呼吸道疾病的鬥爭持續進行，鼻腔疫苗有望發揮更重要的作用。

鼻疫苗市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.56% 左右的複合年成長率成長

根據疫苗類型細分，預計減毒活疫苗將在 2023 年佔據最大市場佔有率

根據交付方式細分，2023年噴霧為主導類型

按地區分類，北美是 2023 年的主要收入來源

鼻疫苗市場-區隔分析：

全球鼻疫苗市場根據疫苗類型、給藥方式、分佈和地區進行細分。

根據疫苗類型，市場分為五類：減毒活疫苗、去活化疫苗、次單位疫苗、重組疫苗和合併疫苗。減毒活疫苗是刺激強烈免疫反應的病毒的弱化版本，由於其具有持久免疫力的潛力，預計將顯著成長。然而，經過工程設計含有可觸發靶向免疫反應的特定抗原的重組疫苗也因其安全性和易於生產而受到關注。

根據輸送方式，市場分為兩類：噴霧和滴注。噴霧預計將成為鼻腔疫苗市場的主要輸送方法。噴霧劑更容易給藥，特別是對於兒童和那些討厭針頭的人，並確保疫苗在鼻腔內更廣泛地分佈，以獲得最佳的免疫反應。

鼻疫苗市場 - 地理洞察

由於成熟的研究基礎設施、政府對疫苗開發的資助以及新技術的高採用率，北美目前佔據了巨大的佔有率。然而，亞太地區預計將出現最快的成長。這是由大量且不斷成長的易患呼吸道疾病的人口、可支配收入增加以及政府促進兒童免疫計劃的舉措等因素推動的。歐洲提供了一個穩定的市場，重點是健全的監管框架和先進的疫苗研究。由於越來越注重改善公共衛生基礎設施和提高對疫苗接種益處的認知，拉丁美洲、中東和非洲的新興市場提供了廣泛的潛力。能夠滿足地區監管要求、解決負擔能力問題並根據當地需求客製化交付系統的製造商將處於有利地位，能夠進入這個不斷擴大的市場。

鼻疫苗市場-競爭格局：

阿斯特捷利康（AstraZeneca）和賽諾菲巴斯德（Sanofi Pasteur）等製藥巨頭因其在疫苗開發和全球分銷網路方面的經驗而擁有強大的影響力。然而，規模較小的生技公司正在透過創新的輸送系統和針對特定呼吸道疾病的利基疫苗取得重大進展。此外，學術機構和研究中心在開發新型鼻疫苗平台方面發揮著至關重要的作用。這些實體之間的策略合作變得越來越普遍，利用綜合專業知識來加速研發。併購也是一個潛在因素，老牌企業尋求擴大其疫苗產品組合或獲得有前景的新技術。這種競爭格局需要注重創新、策略合作夥伴關係，並致力於解決未滿足的醫療需求，以便在不斷成長的鼻疫苗市場中站穩腳跟。

最近的發展：

2023 年1 月，Bharat Biotech International Limited (BBIL) 和生物技術工業研究援助中心(BIRAC) 開發了iNNCOVACC，這是世界上第一個鼻內COVID-19 疫苗，獲得批准用於初級2 劑方案和異源加強劑量。

2023年10月，Mylab和印度血清研究所推出了印度首款無針鼻流感疫苗Nasovac S4。該疫苗含有四種流感病毒株，可透過印度各地的醫療保健提供者和診所獲得，符合世界衛生組織的建議

目錄

第1章：鼻疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按疫苗類型分類的鼻腔疫苗市場片段
    • 以交付方式分類的鼻疫苗市場片段
    • 按分佈分類的鼻腔疫苗市場片段
    • 按國家/地區分類的鼻疫苗市場摘要
    • 按地區分類的鼻腔疫苗市場片段
  • 競爭洞察

第 3 章：鼻腔疫苗主要市場趨勢

  • 鼻疫苗市場促進因素
    • 市場促進因素的影響分析
  • 鼻疫苗市場限制
    • 市場限制影響分析
  • 鼻疫苗市場機會
  • 鼻疫苗市場未來趨勢

第 4 章：鼻疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：鼻腔疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：鼻腔疫苗市場格局

  • 2023 年鼻疫苗市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：鼻腔疫苗市場 - 依疫苗類型

  • 概述
    • 按疫苗類型分類的細分市場佔有率分析
    • 減毒活疫苗
    • 去活化疫苗
    • 亞基
    • 重組
    • 結合疫苗

第 8 章：鼻腔疫苗市場 - 依交付方式

  • 概述
    • 按交付方式分類的細分市場佔有率分析
    • 噴
    • 降低

第 9 章：鼻腔疫苗市場 - 按分佈

  • 概述
    • 按分佈分類的細分市場佔有率分析
    • 民眾
    • 私人的

第 10 章：鼻腔疫苗市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美鼻疫苗主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按疫苗類型）
    • 北美市場規模和預測（按交付方式）
    • 北美市場規模和預測（按分佈）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲鼻疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按疫苗類型）
    • 歐洲市場規模和預測（按交付方式）
    • 歐洲市場規模和預測（按分佈）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區鼻疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依疫苗類型）
    • 亞太地區市場規模與預測（以交付方式）
    • 亞太地區市場規模與預測（按分佈）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲鼻疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按疫苗類型）
    • 拉丁美洲市場規模和預測（以交付方式）
    • 拉丁美洲市場規模與預測（按分佈）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲鼻疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疫苗類型）
    • 中東和非洲市場規模及預測（以交付方式）
    • 中東和非洲市場規模及預測（按分佈）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 鼻疫苗產業

  • 競爭儀表板
  • 公司簡介
    • Altimmune Inc.
    • AstraZeneca PLC
    • Bharat Biotech International Limited
    • BioDiem, Inc.
    • CanSino Biopharmaceuticals Inc.
    • GlaxoSmithKline plc
    • Iovance Biotherapeutics, Inc.
    • Meda Pharma GmbH
    • MeDiVac, Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Seqirus Holdings Pty Ltd
    • Serum Institute of India Pvt. Ltd.
    • TransBio Inc.
    • Vaxlive Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3027

REPORT HIGHLIGHT

Nasal Vaccines Market size was valued at USD 418.9 million in 2023, expanding at a CAGR of 8.56% from 2024 to 2032.

Nasal vaccines, delivered as a spray or mist through the nose, offer a needle-free and potentially more efficient way to trigger immune responses. The growing preference for needle-free vaccinations, particularly among children and needle-phobic individuals. Additionally, nasal vaccines' ability to induce mucosal immunity, potentially providing better protection against respiratory illnesses, fuels market growth. However, challenges like ensuring the stability of the vaccine and navigating stringent regulatory pathways may act as restraints. Exciting opportunities lie in advancements in delivery systems for improved efficacy and the development of vaccines for various respiratory diseases, including COVID-19.

Nasal Vaccines Market- Market Dynamics

Rising prevalence of respiratory infections propelling the market growth

The increasing prevalence of respiratory infections is fueling the growth of the nasal vaccine market, as this technology offers a needle-free alternative to immunization. According to the World Health Organization, respiratory infections account for a significant portion of global mortality, with influenza alone causing an estimated 290,000 to 650,000 deaths annually. This burden, coupled with a growing preference for needle-free vaccinations, is driving the nasal vaccine market. For instance, a recent study published in a reputable medical journal demonstrated that a nasal vaccine for RSV (respiratory syncytial virus) proved effective in protecting infants, highlighting the potential of this. As the fight against respiratory illnesses continues, nasal vaccines are poised to play a more prominent role.

Nasal Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.56% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, Live attenuated vaccines were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Spray was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Nasal Vaccines Market- Segmentation Analysis:

The Global Nasal Vaccines Market is segmented based on Vaccine Type, Delivery Method, Distribution, and Region.

The market is divided into five categories based on Vaccine Type: Live attenuated vaccines, Inactivated vaccines, Subunit, Recombinant, and Conjugate Vaccines. Live attenuated vaccines, weakened versions of the virus that stimulate a strong immune response, are expected to see significant growth due to their potential for long-lasting immunity. However, recombinant vaccines, engineered to contain specific antigens that trigger a targeted immune response, are also gaining traction due to their safety profile and ease of production.

The market is divided into two categories based on the Delivery Method: Spray and Drop. Spray is anticipated to be the dominant delivery method in the nasal vaccine market. Sprays offer greater ease of administration, particularly for children and those with needle aversion, and ensure a wider distribution of the vaccine within the nasal cavity for optimal immune response.

Nasal Vaccines Market- Geographical Insights

North America currently holds a significant share due to established research infrastructure, government funding for vaccine development, and a high adoption rate of new technologies. However, the Asia Pacific region is expected to witness the fastest growth. This is driven by factors like a large and growing population susceptible to respiratory illnesses, rising disposable income, and government initiatives promoting childhood immunization programs. Europe presents a steady market with a focus on robust regulatory frameworks and advanced vaccine research. Emerging markets in Latin America and the Middle East & Africa offer promising potential due to a growing focus on improving public health infrastructure and increasing awareness of vaccination benefits. Manufacturers who can navigate regional regulatory requirements, address affordability concerns, and tailor their delivery systems to suit local needs will be well-positioned to tap into this expanding market.

Nasal Vaccines Market- Competitive Landscape:

Pharmaceutical giants like AstraZeneca and Sanofi Pasteur hold a strong presence due to their experience in vaccine development and global distribution networks. However, smaller biotechnology companies are making significant strides with innovative delivery systems and niche vaccines targeting specific respiratory illnesses. Additionally, academic institutions and research centers play a crucial role in developing novel nasal vaccine platforms. Strategic collaborations between these entities are becoming increasingly common, leveraging combined expertise to accelerate research and development. Mergers and acquisitions are also a potential factor, with established players seeking to expand their vaccine portfolios or gain access to promising new technologies. This competitive landscape necessitates a focus on innovation, strategic partnerships, and a commitment to addressing unmet medical needs to gain a foothold in the growing nasal vaccine market.

Recent Developments:

In January 2023, Bharat Biotech International Limited (BBIL) and Biotechnology Industry Research Assistance (BIRAC) developed iNNCOVACC, the world's first intranasal COVID-19 vaccine to receive approval for the primary 2-dose schedule and as a heterologous booster dose.

In October 2023, Mylab and Serum Institute of India launched Nasovac S4, India's first needle-free nasal influenza vaccine. The vaccine contains four influenza virus strains and is available through healthcare providers and clinics across India, aligning with WHO recommendations

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NASAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Altimmune Inc.

AstraZeneca PLC

Bharat Biotech International Limited

BioDiem, Inc.

CanSino Biopharmaceuticals Inc.

GlaxoSmithKline plc

Iovance Biotherapeutics, Inc.

Meda Pharma GmbH

MeDiVac, Inc.

Pfizer Inc.

Sanofi S.A.

Seqirus Holdings Pty Ltd

Serum Institute of India Pvt. Ltd.

TransBio Inc.

Vaxlive Inc.

Others

GLOBAL NASAL VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Live attenuated vaccines
  • Inactivated vaccines
  • Subunit
  • Recombinant
  • Conjugate Vaccines

GLOBAL NASAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Spray
  • Drop

GLOBAL NASAL VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Public
  • Private

GLOBAL NASAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nasal Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nasal Vaccines Market Snippet by Vaccine Type
    • 2.1.2. Nasal Vaccines Market Snippet by Delivery Method
    • 2.1.3. Nasal Vaccines Market Snippet by Distribution
    • 2.1.4. Nasal Vaccines Market Snippet by Country
    • 2.1.5. Nasal Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Nasal Vaccines Key Market Trends

  • 3.1. Nasal Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nasal Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nasal Vaccines Market Opportunities
  • 3.4. Nasal Vaccines Market Future Trends

4. Nasal Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nasal Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nasal Vaccines Market Landscape

  • 6.1. Nasal Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nasal Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Live attenuated vaccines
    • 7.1.3. Inactivated vaccines
    • 7.1.4. Subunit
    • 7.1.5. Recombinant
    • 7.1.6. Conjugate Vaccines

8. Nasal Vaccines Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 8.1.2. Spray
    • 8.1.3. Drop

9. Nasal Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Public
    • 9.1.3. Private

10. Nasal Vaccines Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nasal Vaccines Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nasal Vaccines Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nasal Vaccines Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Nasal Vaccines Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Nasal Vaccines Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Nasal Vaccines Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Altimmune Inc.
    • 11.2.2. AstraZeneca PLC
    • 11.2.3. Bharat Biotech International Limited
    • 11.2.4. BioDiem, Inc.
    • 11.2.5. CanSino Biopharmaceuticals Inc.
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Iovance Biotherapeutics, Inc.
    • 11.2.8. Meda Pharma GmbH
    • 11.2.9. MeDiVac, Inc.
    • 11.2.10. Pfizer Inc.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. Seqirus Holdings Pty Ltd
    • 11.2.13. Serum Institute of India Pvt. Ltd.
    • 11.2.14. TransBio Inc.
    • 11.2.15. Vaxlive Inc.
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nasal Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Nasal Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Delivery Method Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Delivery Method
  • TABLE Global Nasal Vaccines Market, by Delivery Method 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Nasal Vaccines Market, by Distribution 2019-2032 (USD Million)
  • TABLE Nasal Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nasal Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE North America Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Europe Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Asia Pacific Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Latin America Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Nasal Vaccines Market, by Distribution, 2019-2032 (USD Million)

List of Figures

  • FIGURE Nasal Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2032
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Delivery Method segment market share analysis, 2023 & 2032
  • FIGURE Delivery Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Nasal Vaccines Market share and leading players, 2023
  • FIGURE Europe Nasal Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific Nasal Vaccines Market share and leading players, 2023
  • FIGURE Latin America Nasal Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa Nasal Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Germany Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Nasal Vaccines Market share analysis by country, 2023
  • FIGURE India Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Brazil Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Nasal Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Nasal Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)